Harvesting Extracellular Vesicles (EVs) from blood

This project arises from recent scientific discoveries highlighting the regenerative potential of nanoparticles found in blood, specifically Extracellular Vesicles (EVs). EVs are tiny membrane-bound particles that play a crucial role in cell-to-cell communication and have shown promising therapeutic effects in regenerative medicine. The project will develop methodologies on how on a commercial scale harvest, analysis for quality and ongoing efficacy testing of EV products to develop a commercially viable product. It will also investigate a secondary processing system to convert liquid blood into a stabilized powder more suitable for existing markets. This project aims to not only enhance profitability but also contribute to sustainability by reducing waste and optimising resource utilisation. The project represents a significant opportunity to reposition the industry within the global market for regenerative therapies and healthy ageing solutions.